Skip to main content
. 2011 May 2;301(1):H253–H260. doi: 10.1152/ajpheart.00786.2010

Fig. 1.

Fig. 1.

Systolic function as represented by fractional shortening following in 1-, 3-, or 5-day tamoxifen (TAM) treatment in animals expressing Myh6-MerCreMer (Cre+) or non-Cre (Cre) mice. Day 0 is the average of the 2 baseline measurements and days 2, 4, 6, 8, and 10 represent days following the start of TAM administration. *P < 0.05 vs. Cre/5-day mice.